---
title: "美國食品藥品監督管理局批准簡化患者監測要求並刪除百時美施貴寶細胞療法標籤中的 REMS 計劃。"
description: "美國食品藥品監督管理局批准簡化患者監測要求並刪除百時美施貴寶細胞療法標籤中的 REMS 計劃。"
type: "news"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/246345546.md"
published_at: "2025-06-27T02:09:14.000Z"
---

# 美國食品藥品監督管理局批准簡化患者監測要求並刪除百時美施貴寶細胞療法標籤中的 REMS 計劃。

美國食品藥品監督管理局批准簡化患者監測要求並刪除百時美施貴寶細胞療法標籤中的 REMS 計劃。

### Related Stocks

- [BMY.US - 百時美施貴寶](https://longbridge.com/zh-HK/quote/BMY.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Pfizer Targets Real-World Myeloma Data in Taiwan With New Elranatamab Study | Pfizer Inc. (PFE) is launching a new observational study in Taiwan to evaluate the effectiveness of its multiple myeloma | [Link](https://longbridge.com/zh-HK/news/276252273.md) |
| ICICI Prudential Asset Management Co Ltd Grows Stock Holdings in Bristol Myers Squibb Company $BMY | ICICI Prudential Asset Management Co Ltd increased its stake in Bristol Myers Squibb Company (NYSE:BMY) by 85.8% in Q3,  | [Link](https://longbridge.com/zh-HK/news/276444619.md) |
| Berkshire Hathaway Bought New York Times Stock in Q4. Should You Add NYT to Your Portfolio Too? | Berkshire Hathaway Bought New York Times Stock in Q4. Should You Add NYT to Your Portfolio Too? | [Link](https://longbridge.com/zh-HK/news/276265837.md) |
| Hasbro Enters Into Fourth Amended Revolving Credit Agreement | Hasbro Inc :HASBRO INC - ENTERS INTO FOURTH AMENDED REVOLVING CREDIT AGREEMENT - SEC FILINGHASBRO INC - SECURES $1.1 BIL | [Link](https://longbridge.com/zh-HK/news/276493551.md) |
| What Analysts Are Saying About Bristol-Myers Squibb Stock | 16 analysts have evaluated Bristol-Myers Squibb (NYSE:BMY), revealing mixed sentiments with 4 bullish, 3 somewhat bullis | [Link](https://longbridge.com/zh-HK/news/276477307.md) |

---

> **免責聲明**：本文內容僅供參考，不構成任何投資建議。